This narrative review summarizes the natural history, diagnosis, and management of hazelnut allergy, highlighting that hazelnut allergy is the most prevalent tree nut allergy in Europe and often persists lifelong.
Children · 5 authors, 4 centres
This summary was generated by AI from a single paper. It has not been reviewed by a clinician and is not clinical advice. Verify against the source before acting on it.
This narrative review summarizes the natural history, diagnosis, and management of hazelnut allergy, highlighting that hazelnut allergy is the most prevalent tree nut allergy in Europe and often persists lifelong.
This narrative review synthesizes current evidence on the natural history, diagnosis, and treatment of hazelnut allergy. Allergy to hazelnut, like other tree nut allergies, tends to persist throughout life, with only a minority improving during adolescence. Oral allergen immunotherapy (AIT), alone or combined with monoclonal antibodies, is described as a promising approach to increase tolerance and reduce severity of accidental reactions, though evidence remains limited with no standardized protocol and no long-term tolerance data.